Results 211 to 220 of about 808,060 (334)

The Relationship Between Aldose Reductase and Isoxazole Derivatives: An In Vitro and In Silico Approach to Its Correlation With Diabetic Conditions

open access: yesBiotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Diabetes mellitus (DM), which can result in a number of problems such as cataracts, neuropathy, retinopathy, nephropathy, and several cardiovascular illnesses, continues to be a growing issue despite major advancements in treatment approaches.
Ahmet Esat Göner, Hatice Esra Duran
wiley   +1 more source

It's Magic

open access: yesJournal of the Royal College of Physicians of London, 1988
openaire   +2 more sources

Extended Cycle Life in Lithium‐Ion Batteries through Lithium Supplementation from Li2C4O4@SiO2 Microcapsules

open access: yesBatteries &Supercaps, EarlyView.
The use of Li2C4O4@SiO2 microcapsules, in which Li2C4O4 serves as an additional source of lithium ions and the porous SiO2 shell shields direct contact between the active material and Li2C4O4, enables an additional supply of lithium ions in the battery cell.
Bhupender Pal   +3 more
wiley   +1 more source

Refinement of day 28 treatment response criteria for acute GVHD: a collaboration study of the JSTCT and MAGIC. [PDF]

open access: yesBlood Adv
Akahoshi Y   +31 more
europepmc   +1 more source

Long‐Term Cycling Stability of Sodium/Sodium Ion Cells Probed by In Situ Solid‐State NMR Spectroscopy

open access: yesBatteries &Supercaps, EarlyView.
The suitability of 23Na in situ solid‐state nuclear magnetic resonance (NMR) spectroscopy for long‐term studies of sodium/sodium ion cells is tested. Using silicon carbonitride and hard carbon working electrodes, local structures are analyzed up to the point of capacity degradation and cell failure.
Sonja Egert   +7 more
wiley   +1 more source

Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley   +1 more source

Home - About - Disclaimer - Privacy